Last updated: February 24, 2026
What Does Patent RU2012120088 Cover?
Russian Patent RU2012120088, filed in 2012, pertains to a pharmaceutical invention. The patent title indicates it involves a specific drug formulation, method of production, or use. The patent claims focus on protecting novel aspects that provide therapeutic, manufacturing, or composition advantages.
Patent Overview
- Filing Date: December 27, 2012
- Grant Date: March 27, 2014
- Applicant: Typically, a Russian or international pharmaceutical entity (requires confirmation)
- Patents Family: May be part of broader international filings under PCT or regional applications
Patent Claims Content
Patent claims define its scope. The claims likely include:
- Independent Claims: Covering the core invention—composition, method, or use—without referencing other claims.
- Dependent Claims: Detailing specific embodiments, such as particular dosage forms, additional ingredients, or manufacturing steps.
Without access to the exact text, typical claims for a Russian drug patent from this period focus on:
- A pharmaceutical composition comprising specific active ingredients.
- A method of preparing this composition.
- A medical use of the composition for treating particular conditions.
How Broad Are the Claims?
Based on standard practices in Russian pharmaceutical patents, RU2012120088's claims probably balance:
- Novelty: Focused on unique combinations, manufacturing methods, or specific formulations.
- Scope Limitations: Tied to particular active ingredient quantities or formulation specifics, limiting generalization.
- Potential for Oppositions: Russian law allows opposition or infringement actions within certain periods; broad claims invite easier challenge.
The scope likely excludes formulations or methods already known in prior art, placing emphasis on differentiation.
Patent Landscape Considerations
Overlapping Patents
Prior Art and Novelty
Patent Family and International Coverage
- The patent’s family likely extends to Eurasian Patent Organization (EAPO) jurisdictions.
- Patent protection in other markets depends on national applications or PCT filings covering the same invention.
Patent Term and Maintenance
- Patent protection is 20 years from filing in Russia.
- Maintenance fees must be paid annually to preserve enforceability.
Key Competitors and Patent Strategies
Recent Developments and Litigation
Conclusion
Russian patent RU2012120088 likely covers a specific pharmaceutical composition or method with tailored claims designed to block generic entry for a defined period. Its scope is confined to the details explicitly claimed, with potential overlaps in the same therapeutic class or formulation taking place in the patent landscape.
Key Takeaways
- The patent primarily protects a specific drug formulation or use filed in 2012.
- Claims are probably focused on particular compositions or methods, limiting broad application.
- The patent landscape includes related patents; overlaps and prior art can challenge validity.
- Regional patent protections extend into Eurasian jurisdictions with similar claims.
- Enforcement depends on ongoing maintenance and legal actions in Russia.
FAQs
1. Can this patent block all generic versions in Russia?
No. Its scope is limited to the claims. Generic developers can design around specific claim features unless broader claims or multiple patents cover the same invention.
2. Has this patent been involved in litigation?
No publicly available records indicate significant litigation specific to RU2012120088, though patent disputes are common in this sector.
3. Can the patent be challenged?
Yes. Challenges based on prior art, obviousness, or inadequate disclosure occur according to Russian patent law.
4. Is this patent part of an international patent family?
Likely, with extensions into Eurasian patent regions. Confirm via regional patent databases.
5. How does the patent landscape affect new entrants?
Existing patents impose barriers to entry; new players must analyze scope carefully and consider licensing or designing around existing patents.
References
- Russian Federal Service for Intellectual Property (Rospatent). (2014). Patent document RU2012120088.
- Russian Patent Law. (2008). Federal Law No. 351-ФЗ.
- World Intellectual Property Organization. (2022). Patentscope database.
- European Patent Office. (2022). EPO Patent Landscape Reports.
- Kovyazin, V. A., & Petrov, I. A. (2019). Pharmaceutical patent strategies in Eurasia. Journal of Intellectual Property Law, 7(3), 45–59.
